Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(2S)-2-[(4R)-2-oxo-4-propyltetrahydro-1H-pyrrol-1-yl] butanamide

EU orphan designation number: EU/3/05/315   
Active ingredient: (2S)-2-[(4R)-2-oxo-4-propyltetrahydro-1H-pyrrol-1-yl] butanamide
Indication: Treatment of progressive myoclonic epilepsies
Sponsor: UCB Pharma S.A.
Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2005 Centralised Orphan - Designation EMEA/OD/044/05 (2005)3319 of 26/08/2005
12/07/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/044/05/T/01 (2007)3435 of 10/07/2007